Implementing a Screening and Treatment Protocol for Latent Tuberculosis in Patients With Hematologic Malignancies in a Southern California Medical Center

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2014.11.412
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Screening for Latent Tuberculosis

JAMA - Journal of the American Medical Association
Medicine
2016English

A Higher Prevalence of Hematologic Malignancies in Patients With Thalassemia: Background and Culprits

American Journal of Hematology
Hematology
2017English

Successful Treatment of Trichosporon Asahii Fungemia With Isavuconazole in a Patient With Hematologic Malignancies

Infection and Drug Resistance
Infectious DiseasesPharmacology
2019English

Bispecific Antibodies in the Treatment of Hematologic Malignancies

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

QuantiFERON-TB Gold Test for Screening Latent Tuberculosis Infection in Hemodialysis Patients

Tuberkuloz ve Toraks
PulmonaryCritical CareRespiratory MedicineSurgeryIntensive Care Medicine
2011English

Hematologic Malignancies

Oncologist
Cancer ResearchMedicineOncology
1999English

Chylothorax in Hematologic Malignancies

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Benefit of Treatment of Latent Tuberculosis Infection in Individual Patients

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2015English

Immune Checkpoint Blockade for Hematologic Malignancies: A Review

Stem Cell Investigation
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy